|
|
|
|
|
| April 28,
2011 | ISSUE NUMBER 197 VOL 8 |
Regulatory
A Blueprint for FDA Reform
The FDA five-year strategy emphasizes a more coordinated—and skeptical—response to globalization of the drug supply chain...Read more
Advertisement
 Sales Force Effectiveness USA Summit, May 18-19, New Brunswick
Back for a 9th successful year, this is the biggest sales event in the US. This year we have focused tracks, keynote presentations from other regulated industries incl Citibank and Google, interactive panel sessions with payors and physicians & exclusive pharma only pre-conference workshops.
Find out more: http://www.eyeforpharma.com/sfeusa/.
|
Health Economics
More States Follow Washington's Value-Based Lead
Cameron McClearn looks at how Washington state's value-based approach to healthcare is beginning to influence its neighbors...Read more
Big Pharma
First Orphan Drug Distribution Deal for AstraZeneca
Vandetanib is first treatment AZ has developed and brought to market under orphan drug designation in the US...Read more
Emerging Markets
Looking Beyond the Heady Growth Numbers
A sweet helping of "Turkish delight" for local generic producers amounts to harsh medicine for foreign innovator firms...Read more
Global
Warner Chilcott 'Restructures' International Operations
The Dublin-based company's European operations face the ax, but is that good news for the US?...Read more
|
|
|
 // Biopharmaceutical company Alimera Sciences (Atlanta, Ga.) announced that Dr. Glen Bradley has joined its Board of Directors and the Audit Committee of the Board. Dr. Bradley joined following the resignation of Dr. Anders D. Hove. // Aegerion Pharmaceuticals (Cambridge, Mass.) appointed Sol J. Barer, Ph.D., Chairman of Celgene, to its Board of Directors. Dr. Barer will also serve as Chair of the Compensation Committee. //
Healthcare media strategist Pamela Lippincott has rejoined Spectrum (Washington, D.C.), an independent health and science communications firm, as Vice President of Strategy Development. //
Acura Pharmaceuticals (Palatine, Ill.) announced that President and Chief Executive Officer Andy Reddick has begun a leave of absence for health reasons for an as-yet-undetermined period. // David L. Lowrance has joined Acucela (Seattle, Wash.) as Chief Financial Officer. // |
|
|
|
|
|
 |
|
|
| |
|
| |
|
| |
|
 |
|
 |
| In which areas will your company be increasing its investment the most this year? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
